Zenas Biopharma
ZBIO28.0800.35% ( -0.100 )
已收盘: 10月21日 16:00:00 (美东)全部股东
股东类型
- 机构投资者75.35%
- 上市公司12.35%
- 风投/私募11.08%
- 个人与内部人士1.21%
- 私营企业0.00%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
FMR LLC | 14.59% | 950.67 万 | 0.03% | +42.47 万 | |
InnoCare Pharma Limited | 10.74% | 700.00 万 | 2.84% | +200.00 万 | |
Wellington Management Group LLP | 10.07% | 656.61 万 | 7.56% | +497.23 万 | |
SR One Capital Management, LP | 7.73% | 503.79 万 | 0.23% | +0 | |
New Enterprise Associates, Inc. | 6.17% | 402.32 万 | 0.28% | +0 | |
Zebra Aggregator, LP | 4.98% | 324.54 万 | -- | +324.54 万 | |
Federated Hermes, Inc. | 4.78% | 311.68 万 | 0.23% | -1.02 万 | |
Xencor, Inc. | 4.75% | 309.84 万 | 0.21% | +0 | |
BlackRock, Inc. | 4.12% | 268.62 万 | 0.86% | +64.87 万 | |
Longitude Capital Management Co., LLC | 4.00% | 260.72 万 | 0.18% | +0 | |
Capital Research and Management Company | 3.84% | 250.29 万 | 0.06% | +6.89 万 | |
Polar Capital Holdings Plc | 3.70% | 241.28 万 | 0.38% | -13.57 万 | |
RP Management, LLC | 3.66% | 238.82 万 | 0.16% | +0 | |
Fairmount Funds Management LLC | 3.62% | 235.90 万 | 0.16% | +0 | |
State Street Investment Management | 3.15% | 205.51 万 | 0.80% | +58.42 万 | |
NVP Associates, LLC | 2.82% | 183.85 万 | 0.13% | +0 | |
Tellus BioVentures, LLC | 2.74% | 178.60 万 | 0.03% | +6.00 万 | |
Vanguard Capital Management, LLC | 2.47% | 160.95 万 | 0.19% | +18.47 万 | |
Bank of America Corporation | 1.89% | 123.12 万 | 1.27% | +84.28 万 | |
T. Rowe Price Group, Inc. | 1.88% | 122.69 万 | 1.31% | +86.97 万 |